This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Report Summary

Infection preventionists, environmental services directors, purchasing managers and members of the hospital C-suite are finding themselves at the intersection of cost and quality when it comes to evaluating technology for the prevention of healthcare-associated infections (HAIs). In this report, we take a look at the fiscal trends affecting hospital reimbursement, the necessity of achieving return on investment (ROI), and the importance of making an effective business case for infection control-related services and technologies.

Editor's Take

Making the business case for infection prevention-related products and services to help avoid hospital-acquired conditions and infections -- and hospital readmissions -- is an imperative within the value-based purchasing framework. This report helps infection preventionists and members of the hospital C-suite understand how to find ROI in a technology-related capital purchase.

Takeaways for Your Business

  • Review healthcare reform's impact on purchasing and reimbursement
  • Explore the steps of making an effective business case
  • Discover how automated area decontamination technology can assist in infection prevention